Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

An open-trial evaluation of mitoxantrone in the treatment of progressive MS.

Noseworthy JH, Hopkins MB, Vandervoort MK, Karlik SJ, Lee DH, Penman M, Rice GP, Grinwich KD, Cauvier H, Harris BJ, et al.

Neurology. 1993 Jul;43(7):1401-6.

PMID:
8327145
2.

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP.

CNS Drugs. 2004;18(6):379-96. Review.

PMID:
15089110
3.

Management of worsening multiple sclerosis with mitoxantrone: a review.

Fox EJ.

Clin Ther. 2006 Apr;28(4):461-74. Review.

PMID:
16750460
4.

[Evaluation of the long term effect of mitoxantrone on neurological disability in patients with active multiple sclerosis].

Mesaros S, Stojsavljević N, Dujmović I, Mandić E, Drulović J.

Srp Arh Celok Lek. 2004 Jul-Aug;132(7-8):209-13. Serbian.

5.

Effect of mitoxantrone on MRI in progressive MS: results of the MIMS trial.

Krapf H, Morrissey SP, Zenker O, Zwingers T, Gonsette R, Hartung HP; MIMS Study Group.

Neurology. 2005 Sep 13;65(5):690-5.

PMID:
16157900
6.

A double-blind clinical trial of mitoxantrone versus methylprednisolone in relapsing, secondary progressive multiple sclerosis.

van de Wyngaert FA, Beguin C, D'Hooghe MB, Dooms G, Lissoir F, Carton H, Sindic CJ.

Acta Neurol Belg. 2001 Dec;101(4):210-6.

PMID:
11851027
7.

Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome.

Millefiorini E, Gasperini C, Pozzilli C, D'Andrea F, Bastianello S, Trojano M, Morino S, Morra VB, Bozzao A, Calo' A, Bernini ML, Gambi D, Prencipe M.

J Neurol. 1997 Mar;244(3):153-9.

PMID:
9050955
8.

Intravenous mitoxantrone and cyclophosphamide as second-line therapy in multiple sclerosis: an open-label comparative study of efficacy and safety.

Zipoli V, Portaccio E, Hakiki B, Siracusa G, Sorbi S, Amato MP.

J Neurol Sci. 2008 Mar 15;266(1-2):25-30. Epub 2007 Sep 17.

PMID:
17870094
9.
11.

Severe delayed heart failure in three multiple sclerosis patients previously treated with mitoxantrone.

Goffette S, van Pesch V, Vanoverschelde JL, Morandini E, Sindic CJ.

J Neurol. 2005 Oct;252(10):1217-22. Epub 2005 Apr 18.

PMID:
15834643
12.
13.

[Mitoxantrone (Novantron) in therapy of severe multiple sclerosis. A retrospective study of 15 patients].

Cursiefen S, Flachenecker P, Rieckmann P, Toyka KV.

Nervenarzt. 1999 Aug;70(8):723-31. Review. German. Erratum in: Nervenarzt 1999 Dec;70(12):1051.

PMID:
10483572
14.

What is new in the treatment of multiple sclerosis?

Weinstock-Guttman B, Jacobs LD.

Drugs. 2000 Mar;59(3):401-10. Review.

PMID:
10776827
15.

A controlled trial of mitoxantrone in multiple sclerosis: serial MRI evaluation at one year.

Bastianello S, Pozzilli C, D'Andrea F, Millefiorini E, Trojano M, Morino S, Gasperini C, Bozzao A, Gallucci M, Andreula C, et al.

Can J Neurol Sci. 1994 Aug;21(3):266-70.

PMID:
8000984
16.

Rationale for the use of mitoxantrone in multiple sclerosis.

Edan G, Morrissey S, Le Page E.

J Neurol Sci. 2004 Aug 15;223(1):35-9. Review.

PMID:
15261558
17.

Mitoxantrone as induction treatment in aggressive relapsing remitting multiple sclerosis: treatment response factors in a 5 year follow-up observational study of 100 consecutive patients.

Le Page E, Leray E, Taurin G, Coustans M, Chaperon J, Morrissey SP, Edan G.

J Neurol Neurosurg Psychiatry. 2008 Jan;79(1):52-6. Epub 2007 Sep 10.

PMID:
17846110
18.

Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot study.

Hurwitz BJ, Jeffery D, Arnason B, Bigley K, Coyle P, Goodin D, Kaba S, Kirzinger S, Lynch S, Mandler R, Mikol D, Rammohan K, Sater R, Sriram S, Thrower B, Boateng F, Jakobs P, Wash MB, Bogumil T.

Clin Ther. 2008 Jun;30(6):1102-12. doi: 10.1016/j.clinthera.2008.06.013.

PMID:
18640466
19.

[Immunosuppressive therapy of multiple sclerosis with mitoxantrone].

Mauch E, Kornhuber HH.

Fortschr Neurol Psychiatr. 1993 Dec;61(12):410-7. German.

PMID:
8112704
20.

Review of mitoxantrone in the treatment of multiple sclerosis.

Jeffery DR, Herndon R.

Neurology. 2004 Dec 28;63(12 Suppl 6):S19-24. Review.

PMID:
15623665

Supplemental Content

Support Center